In the bleeding disorders community, mental health challenges are often the quietest battles — invisible to most, yet deeply felt by patients, caregivers, and even healthcare providers. While research reveals the significant toll these challenges take, the real story lies in the communities that refuse to let those struggles go unanswered.Â
Â
This Pathmakers panel, aligned with Mental Health Awareness Month, is designed to amplify those stories — moving beyond statistics and theory to spotlight the real-world solutions transforming lives right now. Guided by voices from National Member Organizations (NMOs), treatment centers, and advocacy networks across the globe, this conversation will illuminate how grassroots connection, peer support, and policy influence are actively closing the mental health gap for people living with bleeding disorders.Â
Â
Rather than centering on what should be done, this dialogue will focus on what is being done:Â
 This event reflects the shared vision of the World Federation of Hemophilia (WFH) and Sanofi’s Beyond the Bleed platform: to create a global standard where emotional well-being is not a secondary concern, but a central pillar of thriving with a bleeding disorder — sustained by the strength of a connected, compassionate community.
"Mental health in the bleeding disorders community is no longer a silent struggle - it’s a shared journey. From peer networks to policy reform, we’re witnessing a groundswell of action that places emotional well-being at the heart of care. This upcoming virtual event is a testament to the power of lived experience, showing that when communities come together, healing goes beyond the physical - it becomes transformational"
• Members of the global hemophilia advocacy community
• Members of the global rare disease advocacy community
• Hematologists / Paediatric Hematologists / Hematologist-Oncologists
• Health/Rare disease policymakers and NGOs
• Patients, family members and carers of those affected by hemophilia
• Industry stakeholders in hemophilia and other rare diseases/trade associations
• Payers and regulators